HomeCompareAGYTF vs ADC

AGYTF vs ADC: Dividend Comparison 2026

AGYTF yields 1818.18% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGYTF wins by $4103414683.66M in total portfolio value
10 years
AGYTF
AGYTF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full AGYTF calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — AGYTF vs ADC

📍 AGYTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGYTFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGYTF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AGYTF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGYTF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, AGYTF beats the other by $3,147,377,270,375,246.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGYTF + ADC for your $10,000?

AGYTF: 50%ADC: 50%
100% ADC50/50100% AGYTF
Portfolio after 10yr
$2051707342.01M
Annual income
$1,851,398,394,418,027.00/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

AGYTF
No analyst data
Altman Z
-5.5
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGYTF buys
0
ADC buys
7
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$ADC▼ Sell$15,001 - $50,0002026-01-15
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-06-17
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-06-17
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-06-11
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-06-11
Josh Gottheimer🏢 House$ADC▼ Sell$1,001 - $15,0002025-04-09
Josh Gottheimer🏢 House$ADC▲ Buy$1,001 - $15,0002024-04-15
Josh Gottheimer🏢 House$ADC▼ Sell$1,001 - $15,0002024-03-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGYTFADC
Forward yield1818.18%4.11%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$4103414683.84M$176.9K
Annual income after 10y$3,702,796,788,756,407.00$79,647.25
Total dividends collected$4074760433.31M$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: AGYTF vs ADC ($10,000, DRIP)

YearAGYTF PortfolioAGYTF Income/yrADC PortfolioADC Income/yrGap
1← crossover$192,518$181,818.18$10,987$577.21+$181.5KAGYTF
2$3,477,331$3,271,336.99$12,293$855.34+$3.47MAGYTF
3$58,943,217$55,222,471.89$14,088$1,290.70+$58.93MAGYTF
4$937,891,469$874,822,227.57$16,660$1,994.91+$937.87MAGYTF
5$14,012,869,532$13,009,325,660.38$20,525$3,181.85+$14012.85MAGYTF
6$196,647,994,247$181,654,223,846.76$26,654$5,286.90+$196647.97MAGYTF
7$2,592,865,386,485$2,382,452,032,641.56$37,006$9,259.47+$2592865.35MAGYTF
8$32,132,661,421,271$29,358,295,457,731.54$55,862$17,338.74+$32132661.37MAGYTF
9$374,409,247,740,494$340,027,300,019,734.44$93,452$35,300.32+$374409247.65MAGYTF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$176,931$79,647.25+$4103414683.66MAGYTF

AGYTF vs ADC: Complete Analysis 2026

AGYTFStock

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Full AGYTF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this AGYTF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGYTF vs SCHDAGYTF vs JEPIAGYTF vs OAGYTF vs KOAGYTF vs MAINAGYTF vs NNNAGYTF vs EPRTAGYTF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.